相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of the Lactate Dehydrogenase Inhibitor Oxamic Acid against the Fermentative Bacterium Streptococcus mitis/oralis: Bactericidal Effects and Prevention of Daptomycin Resistance In Vitro and in an Ex Vivo Model
Razieh Kebriaei et al.
ANTIBIOTICS-BASEL (2022)
Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020
Nidhi Singh et al.
JAC-ANTIMICROBIAL RESISTANCE (2022)
Metabolic changes associated with adaptive resistance to daptomycin inStreptococcus mitis-oralis
Allison Parrett et al.
BMC MICROBIOLOGY (2020)
Strain-Specific Adaptations ofStreptococcus mitis-oralisto Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics
Nagendra N. Mishra et al.
ANTIBIOTICS-BASEL (2020)
Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model
Razieh Kebriaei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies
Brianne Zapata et al.
CURRENT MICROBIOLOGY (2018)
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs)
Juwon Yim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis
C. Garcia-de-la-Maria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism
Nagendra N. Mishra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis
Henry F. Chambers et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Viridans Group Streptococci in Febrile Neutropenic Cancer Patients: What Should We Fear?
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2014)
Development and Validation of a Clinical Model to Predict the Presence of β-Lactam Resistance in Viridans Group Streptococci Causing Bacteremia in Neutropenic Cancer Patients
Samuel A. Shelburne et al.
CLINICAL INFECTIOUS DISEASES (2014)
Streptococcus mitis Strains Causing Severe Clinical Disease in Cancer Patients
Samuel A. Shelburne et al.
EMERGING INFECTIOUS DISEASES (2014)
Early In Vitro and In Vivo Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin
Cristina Garcia-de-la-Maria et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer
A Safdar et al.
CANCER (2006)
Effect of penicillin resistance on presentation and outcome of nonenterococcal streptococcal infective endocarditis
Ron-Bin Hsu et al.
CARDIOLOGY (2006)
Efficacy of β-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin
C Pichardo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Viridans streptococci bacteremia in children with malignancy: Relevance of species identification and penicillin susceptibility
E Husain et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002
RM Prabhu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Viridans streptococcus bacteremia in children on chemotherapy for cancer: An underestimated problem
R Ahmed et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2003)
Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and ceftriaxone
C Sabella et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer
A Marron et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
